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Abstract: Ten novel 3-[4-(diethylamino)phenyl]-4-substituted-1-ylsulfonyl)sydnones (8a-j) have been synthesized.  
All the synthesized compounds were characterized by IR, 
1H NMR, 
13C NMR spectroscopy and elemental analysis. 
Compound 3-[4-(Diethylamino)phenyl]-4-(piperazin-1-ylsulfonyl)sydnone (8b) and 3-[4-(Diethylamino)phenyl]-4-
[(4-methylpiperazin-1-yl)sulfonyl]sydnone
 
(8d)
 
exhibited highest activity against all tested microorganisms. Some 
compounds were found effectively active against tested organisms. 
 
Keywords: Sydnone; sulfonamide; characterization; antimicrobial. 
 
 
1. Introduction 
 
Considerable attention has recently been paid to finding applications of the mesoionic compounds 
in synthesis and pharmacology. The mesoionic compounds possess structural features which have been of 
considerable  interest  to  medicinal  chemists.  From  literature  survey,  sydnone  derivatives  are  most 
important member of the mesoionic category of compounds. Sydnone derivatives have been viewed as 
exotic  structures  within  the  heterocyclic  community.  With  few  exceptions,  sydnones  are  stable 
compounds that exhibit significant polarity
1. Of the many potential applications of sydnones, the one that 
has attracted the most interest is their biological properties like antimalarial, antitumor, antibacterial, 
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analgesic, antiinflammatory and other antimicrobial activities 
2-6. Great deal of work has been done to 
show that sydnones do undergo electrophilic aromatic substitution at the C-4 position of the ring. A large 
amount of research work and activities has been undertaken to synthesize new derivatives of sydnones 
having different biological activities. Hence it is interesting to synthesize and characterize novel sydnone 
derivatives based on diethylaminobenzene.  
 
2. Results and Discussion  
 
Dehydration of an N-alkyl or aryl N-nitroso-α-amino acid is only general route to sydnones. For 
the formation of sydnones by ring closure of N-substituted N-nitrosoglycines, it is evident that at least one 
hydrogen  atom  is  required  on  the  α-carbon  atom  and  that  the  amino  nitrogen  atom  should  have  a 
substituent  other  than  hydrogen.  However,  when  an  N-alkyl-N-nitroso-α-amino  dicarboxylic  acid  is 
treated  with  acetic  anhydride,  sydnone  ring  competes  with  the  cyclic  acid  anhydride  formation  by 
dehydration  between  the  two  carboxyl  groups  and  the  result  is  rather  complicated.  In  the  case  of 
nitrosoiminodiacetic  acid,  3-carboxy  methyl  sydnone  is  obtained  instead  of  the  corresponding  cyclic 
anhydride
7,8. Synthesis of 3-(4-chlorophenyl) sydnone is described in scheme I.  
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Scheme 1. Synthesis of 3-(4-chlorophenyl) sydnone from 4-chloroaniline 
 
Hydrogen  chloride  is  produced  by  the  reaction  between  3-(4-chlorophenyl)sydnone  (5)  and 
diethyl amine which combines with triethylamine to form triethylammonium chloride, which is required 
to complete the reaction. Compound (6) reacted with chlorosulfonic acid to give corresponding sulfonyl 
chloride which on condensation with different amines resulted in to final compounds. The new procedure 
for the synthesis of 3-[4-(diethylamino)phenyl]-4-(substituted-1-yl sulfonyl) sydnone (8a-j) is shown in Asundaria  et.al., Organic Commun. (2010) 3:2 30-38 
 
32 
scheme II. Yield of the novel compounds were found between 74-89 %, depending upon reactivity of 
secondary amine. All the compounds gave satisfactorily elemental analysis.  
All the compounds were characterized by IR and NMR spectroscopy. The expected spectral features of 
synthesized compounds have been assigned. 
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8a:  O 
8b:  NH 
8c:  CH2 
8d:  N-CH3 
8e:  N-CH2CH3 
8f:  N-C6H5 
8g:  N-C6H4-4-OCH3 
8h: N-C6H3-2,3-Cl 
8i:  N-C6H4-4-F 
8j:  N-C6H3-2,6-Cl 
 
Scheme 2. Synthesis of 3-[4-(diethylamino)phenyl]-4-(substituted-1-yl sulfonyl) sydnone from 3-(4-
diethylaminophenyl) sydnone 
              
Biological  activity:  Antibacterial  activity  of  test  compound  was  assessed  against  micrococcus  are 
Staphylococcus  aureus,  Bacillus  subtilis,  Escherichia  coli,  and  Pseudomonas  aeruginosa  by  broth 
dilution method.
9 Ciprofloxacin was used as reference drug. N,N-dimethylformamide (DMF) was used as 
solvent for this activity. The twofold dilution of the compounds were prepared (128, 64, 32, 16, 8, 4, 2, 1, 
0.5,  0.25,  0.125  >)  µg/mL  in  the  same  solvent  for  Minimal  Inhibitory  Concentration  (MIC).  The 
compounds were screened under identical conditions at a dose of 200 µg/mL with DMF as solvent.    
Compound 8d with substitution of 4-methylpiperazin showed enhanced activity against B. Subtilis, E.Coli 
and P. aeruginosa compared to other compounds. Presence of methyl group at 4
th position of piperazine 
ring could be responsible for enhance activity against these species. The structure variation such as ethyl, 
phenyl, methoxy, group at para position of piperazine ring result in to decrease in activity. Compound 8e Novel 3-[4-(diethylamino)phenyl]-4-substituted-1-ylsulfonyl) sydnones  33 
with substitution of ethyl group at para position of piperazine ring showed highest activity against S. 
aureus. Rest of the compounds showed moderate to good activity. This is an example which shows how 
biological activities are influenced by minor structure modification.  
The observed data on the antimicrobial activity of the compounds (8a-j) and the reference drugs are given 
in Table 1. 
 
Table 1. In vitro activity of compounds 3-[4-(diethylamino)phenyl]-4-(substituted-1-ylsulfonyl)sydnone  
(8a-j) 
 
Compound    Gram Possitive Organisms    Gram Negative Organisms 
    S.aureus                          B. Subtilis    E.Coli                  P. aeruginosa 
    IZ  MIC  IZ  MIC    IZ  MIC  IZ  MIC 
 
8a    10  -  18  32    13  64  08  - 
 
8b    12  64  15  64    16  32  18  32 
 
8c    10  -  11  128    09  -  08  - 
 
8d    15  32  21  08    20  08  18  16 
 
8e    18  32  08  -    04  -  05  - 
 
8f    17  32  05  -    11  128  10  - 
 
8g    08  -  12  128    11  128  09  - 
 
8h    05  -  08  -    07  -  08  - 
 
8i    11  128  10  -    12  64  13  64 
 
8j    12  128  11  128    08  -  07  - 
 
Ciprofloxacin  31  01  35  0.5    38  0.25  41  0.125 
# IZ: Inhibition of zone at 200 µg/mL 
MIC: Minimum Inhibitory Concentration 
 
3. Conclusion 
 
Our present investigation is centered on the studies of reactions, synthesis, spectral analysis and 
biological activities of sydnone sulfonamide derivatives. The procedure proved more profitable than those 
previously reported in the literature. Some compounds were found effective as antibacterial agents. 
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4. Experimental 
 
General Procedure: All the melting points reported are uncorrected and were recorded using an electro 
thermal melting point apparatus. Thin layer chromatography (TLC) was performed on E-Merck pre-
coated 60 F254 plates and the spots were rendered visible by exposing to UV light. IR spectra were 
recorded  on  Shimadzu  FTIR  instrument.  NMR  spectra  were  recorded  on  Brucker  Avance  II  NMR 
spectrometer. Chemical shifts (δ) reported are referred to internal reference tetramethyl silane. Elemental 
analysis was obtained using a Carlo-Erba CHNS-O EA 1108 Elemental Analyzer.  
 
Preparation of Ethyl N-(4-chlorophenyl)glycinate (2) : p-Chloroaniline (1.40 g, 0.01 mol),  chloroethyl 
acetate (1.06 mL, 0.01 mol)  in ethanol (10 mL) and anhydrous sodium acetate (1.64 g, 0.02 mol) were  
refluxed for  5 hours. The mixture was diluted with 10 mL of water and kept in refrigerator for overnight. 
Recrystalliaztion in ethanol gave yield 81% of pure glycinate. M.p. 115-117 ºC. (lit.
10m.p. 94 
oC ) IR 
(KBr):  3328,  2951,  2933,  2887,  1757,  1072; 
1H  NMR  (400  MHz,  DMSO-d6):  δ  1.21  (t,  3H, 
COOCH2CH3), 3.76 (s, 1H, NH), 4.29 (s, 2H, CH2), 4.54 (q, 2H, COOCH2CH3), 6.83-7.21 (m, 4H, Ar-
H); 
13C NMR (40 MHz, DMSO-d6): δ 14.67, 44.78, 61.29, 115.12, 123.22, 128.96, 146.26, 172.11. 
 
Preparation of  N-(4-chlorophenyl)glycine (3): Ethyl N-(4-chlorophenyl)glycinate (2.13 g, 0.01 mol) 
and sodium hydroxide (0.6 g, 0.015 mol) in solution of distilled water and ethanol (18 mL:4 mL) was 
heated at 80-85 
0C for 0.5 hour. Allowed to cool and acidified with hydrochloric acid. Crystalline white 
product was obtained. Yield 78%. M.p. 145-147 ºC. (lit.
10 m.p. 144 
oC)
  
IR (KBr): 3323, 3278-2521, 2954, 2937, 2881, 1705, 1067;  
1H NMR (400 MHz, DMSO-d6): δ 4.33 (s, 
2H, CH2), 6.44 (s, 1H, COOH), 6.52 (s, 1H, NH), 6.88-7.23 (m, 4H, Ar-H); 
13C NMR (40 MHz, DMSO-
d6): δ 44.98, 114.32, 123.26, 129.10, 146.07, 172.18. 
 
Preparation of [(4-chlorophenyl)(nitroso)amino]acetic acid (4): To an ice cooled solution of the N-(4-
chlorophenyl) glycine (1.86 g, 0.01 mol) in water (40 mL), a solution of sodium nitrite (0.69 g, 0.01 mol) 
in water (5 mL) was added dropwise with stirring. The reaction mixture was filtered and precipitated by 
adding concentrated hydrochloric acid to the filtrate. Product obtained as yellowish needles. Yield 78%.  
M.p. 104-106 ºC. (lit. 
11 mp 113 
oC. IR (KBr): 3257-2526, 2925, 2853, 1712, 1571, 1328, 1065; 
1H NMR 
(400 MHz, DMSO-d6): δ 5.02 (s, 2H, CH2), 6.93-7.48 (m, 4H, Ar-H), 11.56 (s, 1H, COOH); 
13C NMR 
(40 MHz, DMSO-d6): δ 49.43, 120.78, 128.31, 130.46, 138.89, 168.24. 
 
Preparation of 3-(4-chlorophenyl)sydnone (5): The mixture of [(4-chlorophenyl)(nitroso) amino]acetic 
acid (2.70 g, 0.0126 mol) and acetic anhydride (15 mL) was stirred at room temperature for 12 hours in 
dark. The solution was poured slowly into cold water which was very well stirred. The pH of the content 
was adjusted to 7.0 with 10 % sodium bicarbonate solution. The crude sydnone obtained was washed well 
with water and dried. Recrystalliaztion from 95 % ethanol afforded yield 98% of light yellow needles, 
M.p. 140-145 ºC. (lit.
12 m.p. 110-112 
oC). IR (KBr): 3178, 1750, 1056; 
1H NMR (400 MHz, DMSO-d6): δ 
7.21 (s, 1H, sydnone), 7.52-8.16 (m, 4H, Ar-H); 
13C NMR (40 MHz, DMSO-d6): δ 124.12, 128.55, 
130.63, 135.22, 140.92, 169.19. 
 
Preparation of 3-(4-diethylaminophenyl) sydnone (6):  Diethylamine (1.05 mL, 0.01 mol) was added 
dropwise to the mixture of 3-(4-chlorophenyl) sydnone (1.96 g, 0.01 mol) and triethylamine (1.34 mL, 
0.01 mol) in dimethylformamide (DMF) (10 mL) over the period of 30 minute. The reaction mixture 
heated for about 24 hour at 50 ºC. The solution was poured over the crushed ice. The resulting crystals are 
filtered. Recrystallized from hot water. Yield obtained was about 78 %. M.p. 160-163 ºC. IR (KBr): 3182, 
2956, 2918, 2865, 2823, 1753, 1343; 
1H NMR (400 MHz, DMSO-d6): δ 1.33 (t, 6H, J=7 Hz, CH3), 3.39 Novel 3-[4-(diethylamino)phenyl]-4-substituted-1-ylsulfonyl) sydnones  35 
(q, 4H, J=7 Hz, CH2), 7.11 (s, 1H, sydnone), 7.18-7.64 (m, 4H, Ar-H); 
13C NMR (40 MHz, DMSO-d6): δ 
13.06, 45.13, 116.33, 123.11, 124.43, 140.87, 149.33, 169.24. 
 
Preparation  of  N-(4-diethylaminophenyl)  sydnone  sulphonyl  chloride  (7):  Add  N-(4-
diethylaminophenyl) sydnone (2.33 g, 0.01 mol) in small portion to the mixture of chlororsulphonic acid 
(0.70 mL, 0.01 mol) and catalytic amount of phosphorous pentoxide. Shake well to ensure thorough 
mixing. When the addition has been made, heat the reaction mixture at 60-65 
0C for about 1 hour in order 
to complete the reaction. Allow to cool and pour the mixture over ice. Stir well. Brown solid product was 
obtained. Filter off the product and wash with cold water. Yield is about 89%. M.p. 195-197 ºC. IR 
(KBr): 2963, 2923, 2867, 2836, 1747, 1395, 1345, 1178; 
1H NMR (400 MHz, DMSO-d6): δ 1.36 (t, 6H, J 
= 7, CH3), 3.45 (q, 4H, J = 7 Hz, CH2), 7.13-7.95 (m, 4H, Ar-H); 
13C NMR (40 MHz, DMSO-d6): δ 
13.26, 45.35, 115.86, 117.89, 123.10, 140.90, 149.54, 169.22. 
 
Preparation of 3-[4-(diethylamino)phenyl]-4-(substituted-1-yl sulfonyl) sydnone (8a-j): Various 2º -
amine  (0.005  mol)  in  acetone  (10  mL)  was  added  to  N-(4-diethylaminophenyl)  sydnone  sulphonyl 
chloride (1.65 g, 0.005 mol) with stirring for 4 hour. Add pyridine (2.0 mL) in portion within this period. 
Pour  the  solution  to  the  ice  cold  water.  Products  recrystallized  in  benzene.  Similarly  other  final 
derivatives were prepared.  Yield, Melting point, Elemental analysis of compounds (8a-j) are shown in 
Table 2. 
 
3-[4-(Diethylamino)phenyl]-4-(morpholin-4-ylsulfonyl)sydnone  (8a):  IR  (KBr):  2955,  2928,  2874, 
2844, 1743, 1358, 1349, 1187, 1127;  
1H NMR (400 MHz, DMSO-d6): δ 1.29 (t, 6H, J=7 Hz, CH3), 3.37 
(q, 4H, J=7 Hz, CH2), 3.54-3.70 (m, 8H, morpholine), 7.10-7.89 (m, 4H, Ar-H); 
13C NMR (40 MHz, 
DMSO-d6): δ 13.12, 45.21, 42.78, 63.54, 116.76, 123.26, 124.10, 140.92, 150.10, 169.19. 
 
3-[4-(Diethylamino)phenyl]-4-(piperazin-1-ylsulfonyl)sydnone  (8b):  IR  (KBr):  3225,  2961,  2926, 
2870, 2830, 1751, 1373, 1342, 1185; 
1H NMR (400 MHz, DMSO-d6): δ 1.28 (t, 6H, J=7 Hz, CH3), 2.61 
(s, 1H, NH), 3.25-3.56 (m, 8H, piperazine), 3.39 (q, 4H, J=7, CH2), 7.12-7.89 (m, 4H, Ar-H);
 13C NMR 
(40 MHz, DMSO-d6): δ 13.42, 41.57, 45.23, 45.37, 116.73, 123.28, 124.61, 150.36, 140.83,  169.15. 
 
3-[4-(Diethylamino)phenyl]-4-(piperidin-1-ylsulfonyl)sydnone  (8c):  IR  (KBr):  2985  (CH3),  2934, 
2875, 2825, 1765, 1370, 1347, 1182; 
1H NMR (400 MHz, DMSO-d6): δ 1.33 (t, 6H, J=7 Hz, CH3), 1.54-
1.60 (m, 6H, piperidine), 3.40 (t, 4H, J=11 Hz, piperidine), 3.45 (q, 4H, J=7 Hz, CH2), 7.12-7.84 (m, 4H, 
Ar-H);
  13C NMR (40 MHz, DMSO-d6): δ 13.32, 23.47, 25.32, 45.21, 45.63, 116.66, 123.35, 124.12, 
140.92, 150.31, 169.36. 
 
3-[4-(Diethylamino)phenyl]-4-[(4-methylpiperazin-1-yl)sulfonyl]sydnone (8d): IR (KBr): 2989, 2977, 
2875, 2852, 1746, 1382, 1363, 1174, 1095; 
1H NMR (400 MHz, DMSO-d6): δ 1.26 (t, 6H, J=7 Hz, CH3), 
2.38 (s, 3H, N-CH3), 2.83 (t, 4H, J=4 Hz, piperazine), 3.38 (q, 4H, J=7 Hz, CH2), 3.58 (t, 4H, J=5 Hz, 
piperazine), 7.10-7.88 (m, 4H, Ar-H);
  13C NMR (40 MHz, DMSO-d6): δ 13.37, 42.45, 45.27, 45.73, 
52.78, 116.54, 123.72, 124.09, 150.57, 140.78, 169.16. 
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Table 2. Analysis of 3-[4-(diethylamino)phenyl]-4-(substituted-1-ylsulfonyl)sydnone (8a-j) 
 
               R  Mol. Formula  Yield                    M.P  Analysis 
      (Mol. Weight)  %  
0C  Calcd/found 
              %C  %H  %O  %N  %S 
 
8a  morpholine  C16H22N4O5S  87  204-206  50.25  5.80  20.92  14.65  5.47 
    (382.43)      (50.35)  (5.86)  (21.14)  (14.62)  (5.56) 
 
8b  piperazine  C16H23N5O4S  89  185-187  50.38  6.08  16.78  18.36   5.48 
    (381.45)      (50.26)  (5.98)  (16.49)  (18.12)  (5.55) 
 
8c  piperidine  C17H24N4O4S  82  224-226  53.67  6.36  16.82  14.73   5.50 
    (380.46)      (53.96)  (6.54)  (16.96)  (14.87)  (5.58) 
 
8d  N-methyl piperazine  C17H25N5O4S  78  195-197  51.63  6.37  16.18  17.71   5.23 
    (395.48)      (51.87)  (6.68)  (16.26)  (17.78)  (5.31) 
 
8e  N-ethyl piperazine  C18H27N5O4S  76  243-245  52.79  6.65  15.63  17.10   5.00 
    (409.50)    (52.54)  (6.96)  (15.72)  (16.98)  (4.90) 
     
8f  N-phenyl piperazine  C22H27N5O4S  79  210-212  57.75  5.95  13.99  15.31   4.35 
    (457.55)      (57.69)  (6.03)  (13.91)  (15.56)  (4.43) 
 
8g  N-4-methoxyphenyl-  C23H29N5O5S  74  201-203  56.66  6.00  16.41  14.36   4.02 
  piperazine  (487.57)        (56.76)  (6.13)  (16.33)  (14.28)  (4.11) 
     
8h  N-2,3-dichlorophenyl-  C22H25Cl2N5O4S  82  173-175  50.19  4.79  12.16  13.30   3.67 
  piperazine  (526.44)        (50.32)    (4.86)  (12.28)  (13.22)  (3.61) 
     
8i  N-4-florophenyl-  C24H26FN5O4S  81  215-217  55.57  5.51  13.46  14.73   4.15 
  piperazine  (475.54)      (55.68)  (5.65)  (13.41)  (14.86)  (4.09) 
     
8j  N-2,6-dichlorophenyl  C22H25Cl2N5O4S  74  238-240  50.19  4.79  12.16  13.30   3.67 
  piperazine  (526.44)  (50.02)  (5.01)  (12.31)  (13.42)  (3.74) 
 
 
 37 
 
 
 
 
3-[4-(Diethylamino)phenyl]-4-[(4-ethylpiperazin-1-yl)sulfonyl]sydnone  (8e):  IR  (KBr):  2978, 
2964, 2870, 2857, 1757, 1388, 1368, 1177, 1087; 
1H NMR (400 MHz, DMSO-d6): δ 1.23 (t, 3H, J=7 
Hz, CH3), 1.47 (t, 6H, J=6 Hz, CH3), 2.88 (q, 2H, J=4 Hz, CH2), 2.91 (t, 4H, J= 4 Hz, piperazine), 
3.45 (q, 4H, J=7 Hz, CH2), 3.73 (t, 4H, J=5 Hz, piperazine), 7.18-7.84 (m, 4H, Ar-H);
 13C NMR (40 
MHz, DMSO-d6): δ 11.48, 13.25, 41.33, 45.27, 50.63, 51.75, 116.76, 123.25, 124.26, 140.74, 150.33, 
169.54 
 
3-[4-(Diethylamino)phenyl]-4-[(4-phenylpiperazin-1-yl)sulfonyl]sydnone  (8f):  IR  (KBr):  2979, 
2974, 2878, 2858, 1741, 1368, 1375, 1171, 1083; 
1H NMR (400 MHz, DMSO-d6): δ 1.35 (t, 6H, J=7 
Hz, CH3), 3.47 (q, 4H, J=6 Hz, CH2), 3.76-3.83 (m, 8H, piperazine), 6.82-7.76 (m, 9H, Ar-H);
 13C 
NMR (40 MHz, DMSO-d6): δ 13.53, 45.25, 45.54, 50.35, 116.88, 117.00, 120.24, 123.35, 124.42, 
129.42, 140.66, 150.37, 153.46, 169.43. 
 
3-[4-(Diethylamino)phenyl]-4-{[4-(4-methoxyphenyl)piperazin-1-yl]sulfonyl}sydnone  (8g):  IR 
(KBr): 2990, 2977, 2876, 2852, 1747, 1364, 1382, 1239, 1174, 1087, 1023; 
1H NMR (400 MHz, 
DMSO-d6): δ 1.41 (t, 6H, J=7 Hz, CH3), 3.33 (q, 4H, J=7 Hz, CH2), 3.69-3.75 (m, 8H, piperazine), 
3.71 (s, 3H, OCH3), 6.85-8.76 (m, 8H, Ar-H).
 13C NMR (40 MHz, DMSO-d6): δ 13.34, 45.24, 45.67, 
50.83, 54.96, 114.63, 116.56, 119.58, 123.27, 124.51, 140.73, 145.65, 150.13, 154.74, 168.68. 
 
3-[4-(Diethylamino)phenyl]-4-{[4-(2,3-dichlorophenyl)piperazin-1-yl]sulfonyl}sydnone  (8h):  IR 
(KBr): 2968, 2945, 2852, 2861, 1756, 1374, 1359, 1172 , 1092, 1090; 
1H NMR (400 MHz, DMSO-
d6): δ 1.27 (t, 6H, J=7 Hz, CH3), 3.38 (q, 4H, J=7 Hz, CH2), 3.79-3.85 (m, 8H, piperazine), 6.95-7.84 
(m, 7H, Ar-H);
 13C NMR (40 MHz, DMSO-d6): δ 13.53, 45.23, 45.43, 51.44, 116.62, 118.34, 122.23, 
123.18, 123.81, 124.31, 129.58, 136.28, 140.35, 147.87, 150.53, 169.26. 
 
3-[4-(Diethylamino)phenyl]-4-{[4-(4-fluorophenyl)piperazin-1-yl]sulfonyl}sydnone (8i): IR (KBr): 
2989, 2973, 2872, 2854, 1752, 1378, 1386, 1227, 1162, 1077; 
1H NMR (400 MHz, DMSO-d6): δ 1.22 
(t, 6H, J=7 Hz, CH3), 3.40 (q, 4H, J=7 Hz, CH2), 3.67-3.75 (m, 8H, piperazine), 7.00-8.23 (m, 8H, Ar-
H);
  13C NMR (40 MHz, DMSO-d6): δ 13.33, 45.26, 45.34, 51.21, 115.86, 116.47, 116.56, 123.15, 
124.64, 140.36, 149.12, 150.35, 156.48, 169.30. 
3-[4-(Diethylamino)phenyl]-4-{[4-(2,6-dichlorophenyl)piperazin-1-yl]sulfonyl}sydnone  (8j):  IR 
(KBr): 2975, 2964, 2877, 2856, 1766, 1384, 1358, 1176, 1095, 1084; 
1H NMR (400 MHz, DMSO-d6): 
δ 1.31 (t, 6H, J=7 Hz, CH3), 3.36 (q, 4H, J=7 Hz, CH2), 3.79-3.85 (m, 8H, piperazine), 6.95-7.50 (m, 
7H, Ar-H); 
13C NMR (40 MHz, DMSO-d6): δ 13.14, 45.24, 45.33, 51.43, 116.76, 123.22, 124.12, 
126.33, 128.45, 136.77, 140.66, 143.54, 150.17, 169.22. 
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